ArticleMolecules (Basel, Switzerland)2025
Green Synthesis of Gallium-Based Metal-Organic Frameworks with Antibacterial Properties.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- One-Step Sol-Gel-Fabricated CuZn Alloy Aerogel Enabled by Cu-Zn Bimetallic Synergy for Efficient Antibacterial and Anti-Biofilm Therapy.Gels (Basel, Switzerland) · 2026Article
- Room-Temperature Aqueous Synthesis of Amino-Functionalized Al-Based MOF as a Ratiometric Fluorescent Probe for Aqueous Dichromate Detection.Molecules (Basel, Switzerland) · 2026Article
- Application of Metal-Organic Framework-Based Electrochemiluminescence Sensors for Mycotoxin Detection in Food.Biosensors · 2026Review
- A Green-Synthesized Zr-Tb Bimetallic MOF: Ratiometric Fluorescent Probe for Selective and Sensitive Detection of Ciprofloxacin.Molecules (Basel, Switzerland) · 2026Article
- Antibacterial silver nanoparticle decorated gallium metal-organic frameworks for odontogenic infections.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Bacterial drug resistance has become increasingly severe, with the development of novel antibiotics lagging far behind the evolution of resistant strains, drastically limiting clinical treatment options. Therefore, the development of new antibacterial materials is urgently needed. In this study, we synthesized a gallium-based metal-organic framework antibacterial material, designated as GM, with gallium as the central atom. Compared to a previously reported gallium-based MOF (FM), GM features a greener and milder synthesis process (room temperature, aqueous solvent, no toxic additives) while exhibiting improved antibacterial performance. Despite sharing identical raw materials, GM and FM are structurally distinct due to differences in synthesis methods, as evidenced by variations in morphology and crystal structure. Antibacterial assays against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.